Male balding is a major risk factor for severe COVID-19.
作者信息
Lee Justin, Yousaf Ahmed, Fang Wei, Kolodney Michael S
机构信息
Department of Dermatology, West Virginia University.
Virginia Clinical and Translational Science Institute, Morgantown, West Virginia.
出版信息
J Am Acad Dermatol. 2020 Nov;83(5):e353-e354. doi: 10.1016/j.jaad.2020.07.062. Epub 2020 Jul 22.
Abstract
摘要
相似文献
1
Male balding is a major risk factor for severe COVID-19.男性脱发是重症新冠病毒肺炎的一个主要风险因素。
J Am Acad Dermatol. 2020 Nov;83(5):e353-e354. doi: 10.1016/j.jaad.2020.07.062. Epub 2020 Jul 22.
2
Androgenetic alopecia in COVID-19: Compared to what?新冠病毒感染中的雄激素性脱发：与什么相比？
J Am Acad Dermatol. 2020 Dec;83(6):e451. doi: 10.1016/j.jaad.2020.06.1031. Epub 2020 Jul 29.
3
Alopecia areata not due by isotretinoin. A thought in COVID-19 time.非异维A酸所致斑秃。新冠疫情期间的思考。
Dermatol Ther. 2020 Jul;33(4):e13451. doi: 10.1111/dth.13451. Epub 2020 May 5.
4
Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals.男性脱发作为重症 COVID-19 的主要风险因素：靶向雄激素和跨膜蛋白酶丝氨酸 2 以保护易感个体的潜在作用。
J Am Acad Dermatol. 2020 Dec;83(6):e401-e402. doi: 10.1016/j.jaad.2020.09.015. Epub 2020 Sep 11.
5
Effects of 5-alpha reductase inhibitors on lung function: A reason for discontinuation during COVID-19 pandemic?5-α还原酶抑制剂对肺功能的影响：在新冠疫情期间停药的一个原因？
Dermatol Ther. 2020 Jul;33(4):e13535. doi: 10.1111/dth.13535. Epub 2020 May 20.
6
Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?生物钟基因可能驱动新冠病毒传染性的季节性变化：秋季我们会迎来第二波新冠疫情吗？
J Biol Regul Homeost Agents. 2020;34(4):1455-1457. doi: 10.23812/20-359-L-35.
7
Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.2019年冠状病毒病（COVID-19）重症和危重症患者的临床病程：一项对比研究。
J Infect. 2020 Aug;81(2):e82-e84. doi: 10.1016/j.jinf.2020.05.021. Epub 2020 May 13.
8
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia.2019冠状病毒病（COVID-19）肺炎母亲所生新生儿中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的垂直传播
Obstet Gynecol. 2020 Sep;136(3):632-633. doi: 10.1097/AOG.0000000000004073.
9
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
10
A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).《关于〈2019年冠状病毒病、中东呼吸综合征和严重急性呼吸综合征的比较概述：综述文章〉的评论》（《国际外科学杂志》2020年；81卷：第1 - 8页）
Int J Surg. 2020 Nov;83:28-29. doi: 10.1016/j.ijsu.2020.08.049. Epub 2020 Sep 11.
引用本文的文献
1
A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections.奥密克戎变异株突破性感染的临床、流行病学和病毒载量评估的 COVID-19 感染回顾性研究。
Int J Med Sci. 2024 Jan 1;21(3):454-463. doi: 10.7150/ijms.87167. eCollection 2024.
2
Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial.普罗芦卡胺（GT0918）治疗 COVID-19 重症或危重症患者的疗效和安全性：一项前瞻性、开放标签、单臂、单中心探索性试验的研究方案。
BMC Pharmacol Toxicol. 2023 Jun 15;24(1):38. doi: 10.1186/s40360-023-00678-7.
3
The Effect of Covid-19 on the Hair Diseases Observed in Health Care Providers: Analysis of 513 Participants.新冠病毒对医护人员所患毛发疾病的影响：对513名参与者的分析。
Dermatol Pract Concept. 2023 Jan 1;13(1):e2023036. doi: 10.5826/dpc.1301a36.
4
The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study.COVID-19 对毛发和甲疾病发展的影响：一项土耳其多中心、对照研究。
Int J Dermatol. 2023 Feb;62(2):202-211. doi: 10.1111/ijd.16454. Epub 2022 Oct 25.
5
Androgens and COVID-19.雄激素与 COVID-19。
J Cosmet Dermatol. 2022 Aug;21(8):3176-3180. doi: 10.1111/jocd.15090. Epub 2022 Jun 21.
6
Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia.新型冠状病毒肺炎中毛发脱落与全身炎症的关系。
Ann Med. 2022 Dec;54(1):869-874. doi: 10.1080/07853890.2022.2054026.
7
Association of androgenetic alopecia with a more severe form of COVID-19 infection.雄激素性脱发与 COVID-19 感染更严重形式相关。
Ir J Med Sci. 2023 Feb;192(1):187-192. doi: 10.1007/s11845-022-02981-4. Epub 2022 Mar 23.
8
"MATH+" Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale.“MATH+”新冠病毒感染多模式医院治疗方案：临床与科学依据
J Clin Med Res. 2022 Feb;14(2):53-79. doi: 10.14740/jocmr4658. Epub 2022 Feb 24.
9
Alopecia in patients with COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎患者的脱发：一项系统评价与荟萃分析
JAAD Int. 2022 Jun;7:67-77. doi: 10.1016/j.jdin.2022.02.006. Epub 2022 Feb 22.
10
Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial.恩杂鲁胺用于住院COVID-19患者的随机、安慰剂对照、双臂平行临床试验的最终结果：Proxa-Rescue AndroCoV试验的多区域联合分析
Cureus. 2021 Dec 25;13(12):e20691. doi: 10.7759/cureus.20691. eCollection 2021 Dec.
本文引用的文献
1
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign".雄激素性脱发在大多数因新冠肺炎住院的患者中出现：“加布林征” 。
J Am Acad Dermatol. 2020 Aug;83(2):680-682. doi: 10.1016/j.jaad.2020.05.079. Epub 2020 May 22.
2
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity.初步观察：西班牙住院 COVID-19 患者中的男性型脱发 - 雄激素在 COVID-19 严重程度中作用的潜在线索。
J Cosmet Dermatol. 2020 Jul;19(7):1545-1547. doi: 10.1111/jocd.13443. Epub 2020 Apr 23.
3
Male pattern baldness: classification and incidence.男性型秃发：分类与发病率
South Med J. 1975 Nov;68(11):1359-65. doi: 10.1097/00007611-197511000-00009.
Zotero 插件